Back
Oracle Corp. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
37
ORCL
Oracle Corp.
Last Price:
$217.57
Seasonality Move:
12.46%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$104.56
Seasonality Move:
-6.7%
Sell
37
Oracle Corp. (ORCL)
is a Sell
Is Oracle Corp. a Buy, Sell or Hold?
-
The current Oracle Corp. [ORCL] share price is $217.58. The Score for ORCL is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
ORCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $104.60. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ORCL Stock Price Chart
What is Oracle Corp.'s stock price today?
-
The Oracle Corp. share price today is $217.58Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ORCL is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $104.60The current trend is moderately bullish and RYTM is experiencing slight selling pressure.
ORCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -13.22 | Sell |
| Relative Strength Index (14 RSI): | 44.28 | Sell |
| Chaikin Money Flow: | 8398932 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.29 - 242.11) | Sell |
| Bollinger Bands (100): | (223.5 - 288.94) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 50.78 | Buy |
| Chaikin Money Flow: | -195325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.6 - 107.92) | Buy |
| Bollinger Bands (100): | (92.83 - 106.97) | Buy |
ORCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 205.7 | Buy |
| 20-day SMA: | 215.24 | Buy |
| 50-day SMA: | 254.62 | Sell |
| 200-day SMA: | 211.87 | Buy |
| 8-day EMA: | 209.8 | Buy |
| 20-day EMA: | 218.9 | Sell |
| 50-day EMA: | 239.33 | Sell |
| 200-day EMA: | 222.51 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.83 | Sell |
| 20-day SMA: | 102.55 | Buy |
| 50-day SMA: | 104.26 | Buy |
| 200-day SMA: | 80.37 | Buy |
| 8-day EMA: | 104.76 | Sell |
| 20-day EMA: | 104.28 | Buy |
| 50-day EMA: | 102.89 | Buy |
| 200-day EMA: | 85.54 | Buy |
Oracle Corp. Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.82 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Oracle Corp. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||